Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Inappropriate attack on device development.
Interpersonal Relations
Investigations of the catalytic mechanism of thioredoxin glutathione reductase from Schistosoma mansoni.
Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancer.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inappropriate attack on device development.
Inappropriate attack on device development. Am J Ther. 2011 Mar-Apr; 18(2):91.
View in:
PubMed
subject areas
Device Approval
Equipment and Supplies
Equipment Design
Equipment Failure
Humans
Safety-Based Medical Device Withdrawals
United States
United States Food and Drug Administration